Cardiovascular outcomes of β‐blocker—calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real‐world retrospective study.

MLA

Lin, Junxiong, et al. “Cardiovascular Outcomes of Β‐blocker—calcium Channel Blocker Initial Dual Therapy vs. Other Initial Dual Therapies in Chinese Patients with Hypertension: A Real‐world Retrospective Study.” Journal of Clinical Hypertension, vol. 25, no. 5, May 2023, pp. 440–52. EBSCOhost, https://doi.org/10.1111/jch.14665.

APA

Lin, J., Guo, Q., Lu, Z., Chai, D., Peng, F., & Lin, J. (2023). Cardiovascular outcomes of β‐blocker—calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real‐world retrospective study. Journal of Clinical Hypertension, 25(5), 440–452. https://doi.org/10.1111/jch.14665

Chicago

Lin, Junxiong, Qinghui Guo, Zhuoqiang Lu, Dajun Chai, Feng Peng, and Jinxiu Lin. 2023. “Cardiovascular Outcomes of Β‐blocker—calcium Channel Blocker Initial Dual Therapy vs. Other Initial Dual Therapies in Chinese Patients with Hypertension: A Real‐world Retrospective Study.” Journal of Clinical Hypertension 25 (5): 440–52. doi:10.1111/jch.14665.